publication venue for
- The Effect of TNF Inhibition on Bone Density and Fracture Risk and of IL17 Inhibition on Radiographic Progression and Bone Density in Patients with Axial Spondyloarthritis: a Systematic Literature Review.. 21. 2019
- Top 10 clinical research developments in antiphospholipid syndrome.. 15. 2013
- Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?. 12. 2010
- Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis.. 10. 2008
- Improving survival in inflammatory rheumatic diseases: a neglected goal?. 8. 2006
- Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.. 23. 2021
- Web alert.. 1. 1999
- Does continued treatment with methotrexate in juvenile idiopathic arthritis in remission prevent flare? 2011
- Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. 2021
- Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS. 2021
- Skin Histology in Systemic Sclerosis: a Relevant Clinical Biomarker. 2020
- Complementary and Alternative Medicine Use in Psoriatic Arthritis Patients: a Review. 2020
- Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome. 2019
- Synovial Tissue: Cellular and Molecular Phenotyping. 2019
- Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis. 2018
- Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018? 2018
- Optimizing Rheumatoid Arthritis Patients for Surgery. 2018
- Current Options and Emerging Biomaterials for Periprosthetic Joint Infection. 2018
- How Can We Improve Disease Education in People with Gout? 2018
- Contribution of Circulatory Disturbances in Subchondral Bone to the Pathophysiology of Osteoarthritis. 2017
- AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update. 2016
- Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events. 2016
- Stress Dose Steroids: Myths and Perioperative Medicine. 2016
- Clinical Trial Design Issues in Systemic Sclerosis: an Update. 2016
- What Causes Lupus Flares? 2016
- Using new oral anticoagulants in patients undergoing major orthopedic surgery. 2015
- Perioperative management of patients with pulmonary hypertension for non-cardiac surgery. 2015
- Cervical spine disease in rheumatoid arthritis: incidence, manifestations, and therapy. 2015
- Postoperative risk of venous thromboembolism in rheumatic disease patients. 2015
- The challenge of bleeding in antiphospholipid antibody-positive patients. 2015
- Fracture liaison services: promoting enhanced bone health care. 2014
- Mechanisms of post-traumatic osteoarthritis after ACL injury. 2014
- Perioperative management of antiphospholipid antibody-positive patients. 2014
- Perioperative infection in the patient with rheumatic disease. 2013
- Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. 2013
- Osteoporosis and orthopedic surgery: effect of bone health on total joint arthroplasty outcome. 2013
- Biomarkers in ANCA-associated vasculitis. 2013
- Changing incidence of orthopedic surgery in rheumatic disease: contributing factors. 2013
- Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery. 2013
- The immune pathogenesis of scleroderma: context is everything. 2013
- The clinical spectrum of juvenile idiopathic arthritis in a large urban population. 2012
- Dendritic cells: novel players in fibrosis and scleroderma. 2012
- Clinical assessment and management of cytopenias in lupus patients. 2011
- Imatinib and the treatment of fibrosis: recent trials and tribulations. 2011
- Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand? 2011
- The long-term impact of rituximab for childhood immune thrombocytopenia. 2010
- Update on pathogenic mechanisms of systemic necrotizing vasculitis. 2008
- Total joint replacement in childhood arthritis. 2008
- The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. 2008
- Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment. 2006
- Autoimmune mechanisms in children with systemic lupus erythematosus. 2005
- Interferon pathway activation in systemic lupus erythematosus. 2005
- Quality of life in children with systemic lupus erythematosus. 2005
- What is antiphospholipid syndrome? 2004
- Update on autoantibodies in rheumatoid arthritis. 2004
- New insights into pregnancy-related complications in systemic lupus erythematosus. 2003
- The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies. 2002
- Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations. 2002
- Update on the management of the pregnant patient with antiphospholipid antibody. 2001
- Osteoarthritis and cartilage: the role of cytokines. 2000
- The pathogenic role of annexin-V in the antiphospholipid syndrome. 2000
- The genetics of rheumatoid arthritis: influences on susceptibility, severity, and treatment response. 1999